Clinical Trials in New York

Showing 6381-6400 of 22,668 trials

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

NCT02496585

The purpose of this study is to find out what effects, good and/or bad, the drug nintedanib in combination with steroids, has on the lungs. Furthermore, such treatments' side effects will be studied together with quality of life. In addition, the investigators would like to determine whether they can find markers in the blood which predict worsening lung injury.

Lung CancerLung Metastases

Memorial Sloan Kettering Cancer Center34 participantsStarted Jul 2015

Boston, Massachusetts, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +9 more locations

COMPLETEDPhase 1< 1 mile

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-5552 monotherapy in adult participants with relapsed/refractory solid tumors and to identify the recommended Phase 2 dose (RP2D).

Solid Tumors

Revolution Medicines, Inc.58 participantsStarted Apr 2021

Irvine, California, United States • Sacramento, California, United States • San Francisco, California, United States +5 more locations

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

Find Trials by Condition in New York

A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Exploratory Evaluation of [11C]MPC6827

Optimizing Strategies to Improve STD Partner Services

A Phase 1b Study of WU-NK-101 in Combination With Cetuximab

A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan

Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia

Fecal Microbiota Transplantation for C Diff Infection

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Conduction System Pacing Optimized Therapy

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence

Hairy Cell Leukemia Patient Data Registry

BAsel Syncope EvaLuation (BASEL IX) Study